EP 1015635 A2 20000705 - DETECTION OF MINIMAL RESIDUAL DISEASE IN LYMPHOID MALIGNANCIES
Title (en)
DETECTION OF MINIMAL RESIDUAL DISEASE IN LYMPHOID MALIGNANCIES
Title (de)
NACHWEIS VON MINIMALEN RESTERKRANKUNGEN BEI LYMPHOID-MALIGNITÄT
Title (fr)
DETECTION D'UNE PATHOLOGIE RESIDUELLE MINIME DANS DES TUMEURS MALIGNES LYMPHOIDES
Publication
Application
Priority
- EP 98944341 A 19980918
- EP 97202858 A 19970918
- NL 9800542 W 19980918
Abstract (en)
[origin: WO9914366A2] The invention relates to the field of cancer diagnosis, more specific to the monitoring of disease development during and after treatment. The invention comprises a method for determining minimal residual disease comprising amplifying nucleic acid molecules using at least one primer reactive with a common gene segment and further comprising identifying malignancy-specific nucleic acid sequences by hybridising with a fluorogenic probe specifically and selectively reactive with said malignancy-specific nucleic acid sequences.
IPC 1-7
IPC 8 full level
C12Q 1/68 (2006.01); C12Q 1/6886 (2018.01)
CPC (source: EP)
C12Q 1/6886 (2013.01); C12Q 2600/118 (2013.01)
Citation (search report)
See references of WO 9914366A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9914366 A2 19990325; WO 9914366 A3 19990506; AU 9190098 A 19990405; CA 2303945 A1 19990325; EP 1015635 A2 20000705
DOCDB simple family (application)
NL 9800542 W 19980918; AU 9190098 A 19980918; CA 2303945 A 19980918; EP 98944341 A 19980918